Last reviewed · How we verify

NCT04998591: KiWuC

Effects of Fasting on Success Rates of Assisted Reproductive Techologies

Terminated NA Last updated 14 December 2022
What this trial tests

NA trial testing Fasting in Sub Fertility, Female in 1 participant. Terminated before completion.

Timeline
3 August 2021
Primary endpoint
12 December 2022
12 December 2022

Quick facts

Lead sponsorCharite University, Berlin, Germany
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment1
Start date3 August 2021
Primary completion12 December 2022
Estimated completion12 December 2022
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Charite University, Berlin, Germany

Who can join

Adults 25 to 38, female only, with Sub Fertility, Female or Fertility Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This exploratory study investigates fasting as a potential supportive therapy for infertility treatment in women undergoing in-vitro-fertilization (IVF) / intracystoplamsatic sperm injection (ICSI)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Fasting

Trials testing the same drug.

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04998591.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing